JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB188319

Anti-Fyn (phospho Y530) + Yes1 (phospho Y537) antibody [EPR13512]

Be the first to review this product! Submit a review

|

(4 Publications)

Rabbit Recombinant Monoclonal FYN phospho Y530 antibody. Suitable for IP, WB and reacts with Human samples. Cited in 4 publications.

View Alternative Names

Tyrosine-protein kinase Fyn, Proto-oncogene Syn, Proto-oncogene c-Fyn, Src-like kinase, p59-Fyn, SLK, FYN

3 Images
Western blot - Anti-Fyn (phospho Y530) + Yes1 (phospho Y537) antibody [EPR13512] (AB188319)
  • WB

Supplier Data

Western blot - Anti-Fyn (phospho Y530) + Yes1 (phospho Y537) antibody [EPR13512] (AB188319)

All lanes:

Western blot - Anti-Fyn (phospho Y530) + Yes1 (phospho Y537) antibody [EPR13512] (ab188319) at 1/20000 dilution

Lane 1:

Lysate from HeLa cells treated with pervanadate at 10 µg

Lane 2:

Lysate from untreated HeLa cells at 10 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugate at 1/1000 dilution

Predicted band size: 61 kDa

Observed band size: 59 kDa

false

Western blot - Anti-Fyn (phospho Y530) + Yes1 (phospho Y537) antibody [EPR13512] (AB188319)
  • WB

Lab

Western blot - Anti-Fyn (phospho Y530) + Yes1 (phospho Y537) antibody [EPR13512] (AB188319)

All lanes:

Western blot - Anti-Fyn (phospho Y530) + Yes1 (phospho Y537) antibody [EPR13512] (ab188319) at 1/10000 dilution

Lane 1:

HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysates at 20 µg

Lane 2:

HeLa (Human cervix adenocarcinoma epithelial cell) treated with 50 nM pervanadate for 1 hour whole cell lysates at 20 µg

Lane 3:

HeLa (Human cervix adenocarcinoma epithelial cell) treated with 50 nM pervanadate for 1 hour whole cell lysates. Then the membrane was incubated with phosphatase at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 61 kDa

Observed band size: 59 kDa

false

Immunoprecipitation - Anti-Fyn (phospho Y530) + Yes1 (phospho Y537) antibody [EPR13512] (AB188319)
  • IP

Unknown

Immunoprecipitation - Anti-Fyn (phospho Y530) + Yes1 (phospho Y537) antibody [EPR13512] (AB188319)

ab188319 (purified) at 1 : 30 dilution (2μg) immunoprecipitating Fyn (phospho Y530) + Yes (phospho Y537) in HeLa treated with 50nM Pervandate for 1h whole cell lysate.
Lane 1 (input) : HeLa (Human cervix adenocarcinoma epithelial cell) treated with 50nM Pervandate for 1h whole cell lysate 10μg
Lane 2 (+) : ab188319 & HeLa treated with 50nM Pervandate for 1h whole cell lysate
Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab188319 in HeLa treated with 50nM Pervandate for 1h whole cell lysate
For western blotting, VeriBlot for IP Detection Reagent (HRP) (ab131366) was used for detection at 1 : 1000 dilution.
Blocking and diluting buffer : 5% NFDM/TBST.

All lanes:

Immunoprecipitation - Anti-Fyn (phospho Y530) + Yes1 (phospho Y537) antibody [EPR13512] (ab188319)

Predicted band size: 61 kDa

false

  • Carrier free

    Anti-Fyn (phospho Y530) + Yes1 (phospho Y537) antibody [EPR13512] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR13512

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

IP, WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/30", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/10000 - 1/50000", "WB-species-notes": "<p></p>" } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Fyn and Yes1 are Src family kinases key players in signal transduction processes within cells. They share similarities in function and mechanism often grouped together due to their roles in cellular phosphorylation events. Fyn and Yes1 have a molecular mass of approximately 59 kDa and are ubiquitously expressed in many tissues including brain thymus and T lymphocytes. Fyn known also as p59fyn contributes significantly to the regulation of immune response and neuronal signaling by phosphorylation of different substrates.
Biological function summary

Fyn and Yes1 influence various cellular processes such as cell growth differentiation and survival. They form part of the larger signaling complexes that regulate cytoskeleton organization helping in maintaining cell structure and motility. When activated they communicate changes in the cellular environment by phosphorylating tyrosine residues on target proteins affecting downstream signaling pathways.

Pathways

Both Fyn and Yes1 play major roles in the mitogen-activated protein kinase (MAPK) pathway and the phosphoinositide 3-kinase (PI3K) pathway. These pathways are fundamental for transmitting extracellular signals to the cell nucleus triggering responses like cell proliferation or survival. Through these pathways Fyn and Yes1 interact with various proteins including phospholipase C-gamma (PLCγ) and SH2 domain-containing proteins. Their activation leads to further signaling cascades that impact cellular outcomes.

Aberrant Fyn and Yes1 activity have been linked to cancer and neurodegenerative disorders. Overexpression or mutation of these kinases can lead to uncontrolled cell proliferation contributing to breast cancer. In the context of neurodegenerative diseases Fyn interacts with the amyloid precursor protein implicated in Alzheimer's disease. Understanding these connections provides potential therapeutic targets for intervention in these conditions.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Non-receptor tyrosine-protein kinase that plays a role in many biological processes including regulation of cell growth and survival, cell adhesion, integrin-mediated signaling, cytoskeletal remodeling, cell motility, immune response and axon guidance (PubMed : 11536198, PubMed : 15489916, PubMed : 15557120, PubMed : 16387660, PubMed : 20100835, PubMed : 7568038, PubMed : 7822789). Inactive FYN is phosphorylated on its C-terminal tail within the catalytic domain (PubMed : 15489916). Following activation by PKA, the protein subsequently associates with PTK2/FAK1, allowing PTK2/FAK1 phosphorylation, activation and targeting to focal adhesions (PubMed : 15489916). Involved in the regulation of cell adhesion and motility through phosphorylation of CTNNB1 (beta-catenin) and CTNND1 (delta-catenin) (PubMed : 17194753). Regulates cytoskeletal remodeling by phosphorylating several proteins including the actin regulator WAS and the microtubule-associated proteins MAP2 and MAPT (PubMed : 14707117, PubMed : 15536091). Promotes cell survival by phosphorylating AGAP2/PIKE-A and preventing its apoptotic cleavage (PubMed : 16841086). Participates in signal transduction pathways that regulate the integrity of the glomerular slit diaphragm (an essential part of the glomerular filter of the kidney) by phosphorylating several slit diaphragm components including NPHS1, KIRREL1 and TRPC6 (PubMed : 14761972, PubMed : 18258597, PubMed : 19179337). Plays a role in neural processes by phosphorylating DPYSL2, a multifunctional adapter protein within the central nervous system, ARHGAP32, a regulator for Rho family GTPases implicated in various neural functions, and SNCA, a small pre-synaptic protein (PubMed : 11162638, PubMed : 12788081, PubMed : 19652227). Involved in reelin signaling by mediating phosphorylation of DAB1 following reelin (RELN)-binding to its receptor (By similarity). Participates in the downstream signaling pathways that lead to T-cell differentiation and proliferation following T-cell receptor (TCR) stimulation (PubMed : 22080863). Phosphorylates PTK2B/PYK2 in response to T-cell receptor activation (PubMed : 20028775). Also participates in negative feedback regulation of TCR signaling through phosphorylation of PAG1, thereby promoting interaction between PAG1 and CSK and recruitment of CSK to lipid rafts (PubMed : 18056706). CSK maintains LCK and FYN in an inactive form (By similarity). Promotes CD28-induced phosphorylation of VAV1 (PubMed : 11005864). In mast cells, phosphorylates CLNK after activation of immunoglobulin epsilon receptor signaling (By similarity). Can also promote CD244-mediated NK cell activation (PubMed : 15713798).
See full target information Tyrosine-protein kinase Fyn phospho Y530

Additional targets

YES1 phospho Y537

Publications (4)

Recent publications for all applications. Explore the full list and refine your search

Journal of the Endocrine Society 7:bvad117 PubMed37766843

2023

Riluzole Suppresses Growth and Enhances Response to Endocrine Therapy in ER+ Breast Cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Ayodeji O Olukoya,Hillary Stires,Shaymaa Bahnassy,Sonali Persaud,Yanira Guerra,Suman Ranjit,Shihong Ma,M Idalia Cruz,Carlos Benitez,Aaron M Rozeboom,Hannah Ceuleers,Deborah L Berry,Britta M Jacobsen,Ganesh V Raj,Rebecca B Riggins

EBioMedicine 86:104374 PubMed36455410

2022

Heat shock protein amplification improves cerebellar myelination in the Npc1 mouse model.

Applications

Unspecified application

Species

Unspecified reactive species

James Gray,María E Fernández-Suárez,Maysa Falah,David Smith,Claire Smith,Ecem Kaya,Ashley M Palmer,Cathrine K Fog,Thomas Kirkegaard,Frances M Platt

Cancer medicine 10:4030-4045 PubMed33987980

2021

IBSP, a potential recurrence biomarker, promotes the progression of colorectal cancer via Fyn/β-catenin signaling pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Yan Chen,Ying Qin,Mengmeng Dai,Liping Liu,Yong Ni,Qinsheng Sun,Lulu Li,Yaoyao Zhou,Cheng Qiu,Yuyang Jiang

International journal of molecular sciences 20: PubMed31717348

2019

Suppression of Human Platelet Activation via Integrin αβ Outside-In Independent Signal and Reduction of the Mortality in Pulmonary Thrombosis by Auraptene.

Applications

Unspecified application

Species

Unspecified reactive species

Chih-Wei Hsia,Cheng-Lin Tsai,Joen-Rong Sheu,Wan-Jung Lu,Chih-Hsuan Hsia,Marappan Velusamy,Thanasekaran Jayakumar,Jiun-Yi Li
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com